Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Inoperable Non-small-lung Cancer”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableStudy completedNCT01951755
What this trial is testing

Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
University of Athens 150
Testing effectiveness (Phase 2)Ended earlyNCT02275806
What this trial is testing

Cisplatin/Irinotecan With Concurrent Radiation for Inoperable NSCLC

Who this might be right for
Lung Neoplasms, Non-Small Cell Lung Cancer
Leo W. Jenkins Cancer Center 4
Testing effectiveness (Phase 2)UnknownNCT01203735
What this trial is testing

Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer

Who this might be right for
Locally Advanced Inoperable Non-small-lung Cancer
Soroka University Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00004202
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Spectrum Pharmaceuticals, Inc
Large-scale testing (Phase 3)Looking for participantsNCT05624996
What this trial is testing

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
NRG Oncology 474
Testing effectiveness (Phase 2)Looking for participantsNCT06775678
What this trial is testing

Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung CancersRadiation Treatment for Tumors
Tianjin Medical University Cancer Institute and Hospital 84
Testing effectiveness (Phase 2)Ended earlyNCT03233724
What this trial is testing

Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas

Who this might be right for
Carcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT01899989
What this trial is testing

Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 39
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Early research (Phase 1)Ended earlyNCT00531076
What this trial is testing

Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer

Who this might be right for
Toxicity
Amsterdam UMC, location VUmc 6
Testing effectiveness (Phase 2)UnknownNCT00178698
What this trial is testing

Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors

Who this might be right for
Neuroendocrine CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+1 more
The University of Texas Health Science Center, Houston 36
Testing effectiveness (Phase 2)WithdrawnNCT02947113
What this trial is testing

Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
The Netherlands Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00683514
What this trial is testing

Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer

Who this might be right for
NSCLC
Pierre Fabre Medicament 201
Large-scale testing (Phase 3)Study completedNCT01134861
What this trial is testing

Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 610
Early research (Phase 1)Ended earlyNCT01124812
What this trial is testing

131I-L19SIP Radioimmunotherapy Combined With Radiochemotherapy in Patients With Locally-advanced Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Philogen S.p.A. 3
Testing effectiveness (Phase 2)Study completedNCT00115518
What this trial is testing

Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Heidelberg University 30
Early research (Phase 1)Ended earlyNCT00062335
What this trial is testing

High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 14
Early research (Phase 1)Active Not RecruitingNCT04676477
What this trial is testing

HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 246
Early research (Phase 1)Study completedNCT00327288
What this trial is testing

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

Who this might be right for
Non-small Cell Lung CancerBreast CancerProstate Cancer
AmpliMed Corporation 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT00334815
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung AdenocarcinomaLung Adenosquamous CarcinomaLung Large Cell Carcinoma+4 more
National Cancer Institute (NCI) 29
Load More Results